How I’m Playing The Red-Hot Small-Cap Biotech Stocks

Government provided liquidity has lifted all boats and removed (most of) the funding risk for dev stage biotechs. At the same time there is a recognition by investors that many biotech firms are not going to see a material impact from the pandemic.